Effects of carfilzomib alone and in combination with cisplatin on the gene expression of Bcl-2 and Bax in ovarian carcinoma cell lines
Background: Carfilzomib (CFZ), a proteasome inhibitor, has demonstrated potential in the treatment of ovarian cancer, including variants that are resistant to cisplatin (Cis).Objectives: This study aims to evaluate the effects of CFZ, both as a monotherapy and in combination with Cis, on the express...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Sadra Danesh Negar
2025-03-01
|
| Series: | Journal of Preventive and Complementary Medicine |
| Subjects: | |
| Online Access: | https://www.jpcmed.com/article_216399_bd98847953a15ea8020a3ebd5742c2b6.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|